Daar, E S <br/><br/>
High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Sep 1990 
 - 6574-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.87.17.6574  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Complex--immunology<br/>Acquired Immunodeficiency Syndrome--microbiology<br/>CD4 Antigens--administration & dosage<br/>Drug Evaluation<br/>HIV-1--immunology<br/>Humans<br/>Neutralization Tests<br/>Recombinant Proteins--administration & dosage